FREMONT, Calif. -- NIDEK Inc.
announced it received FDA marketing clearance for commercial
release of its new MC-300 Multicolor Laser Photocoagulator
System.
The MC-300 laser system, for retinal applications, disease
treatments and management, has been commercially available in
international markets and has received strong reviews and clinical
results from retinal specialists in Asia and Europe, the company
said.
"The NIDEK MC-300 is an outstanding laser for retinal applications,
delivering a suite of advanced technologies to the retinal
specialist,” commented Hideo Ozawa, president and founder of
NIDEK, at a recent product release event. “With the
introduction of the MC-300, NIDEK continues its long-standing
commitment to delivering advanced solutions for all specialties of
ophthalmology, including retinal applications," he said.
With worldwide operations headquartered in Gamagori, Japan, NIDEK
develops, manufactures and sells laser systems and diagnostic
equipment of ophthalmology, optometry, general surgery, gynecology
and cosmetic dermatological surgery. NIDEK distributes its products
through a network of distribution partners and a direct sales
force.
April 2005
Latest News